Warburg Pincus X, L.P. 4
4 · Outset Medical, Inc. · Filed Sep 17, 2020
Insider Transaction Report
Form 4
Warburg Pincus X, L.P.
Director10% Owner
Transactions
- Conversion
Series C Redeemable Convertible Preferred Stock
2020-09-17−179,433→ 0 total(indirect: See footnotes)→ Common Stock (22,713 underlying) - Conversion
Common Stock
2020-09-17+6,196,571→ 8,693,251 total(indirect: See footnotes) - Conversion
Series A Redeemable Convertible Preferred Stock
2020-09-17−38,614,650→ 0 total(indirect: See footnotes)→ Common Stock (3,666,039 underlying) - Conversion
Common Stock
2020-09-17+198,238→ 278,111 total(indirect: See footnotes) - Conversion
Series C Redeemable Convertible Preferred Stock
2020-09-17−5,608,720→ 0 total(indirect: See footnotes)→ Common Stock (709,965 underlying) - Conversion
Series A Redeemable Convertible Preferred Stock
2020-09-17−1,235,350→ 0 total(indirect: See footnotes)→ Common Stock (117,283 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2020-09-17−11,410,489→ 0 total(indirect: See footnotes)→ Common Stock (1,299,946 underlying) - Conversion
Series D Redeemable Convertible Preferred Stock
2020-09-17−99,678→ 0 total(indirect: See footnotes)→ Common Stock (16,655 underlying) - Conversion
Series D Redeemable Convertible Preferred Stock
2020-09-17−3,115,757→ 0 total(indirect: See footnotes)→ Common Stock (520,621 underlying) - Conversion
Series B Redeemable Convertible Preferred Stock
2020-09-17−365,041→ 0 total(indirect: See footnotes)→ Common Stock (41,587 underlying)
Footnotes (9)
- [F1]These securities are held directly by Warburg Pincus X Partners, L.P., a Delaware limited partnership ("WP X Partners").
- [F2]These securities are held directly by WP X Finance, L.P., a Delaware limited partnership ("WP X Finance", and together with WP X Partners, the "WPP Funds"). WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP.
- [F3]Warburg Pincus X, L.P., a Delaware limited partnership ("WP X LP"), is the general partner of WP X and WP X Partners. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP"), is the general partner of WP X LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), is the manager of the WPP Funds.
- [F4]Each of the WPP Funds, WPX GP, WP X, WP X LP, WP X GP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Entities."
- [F5]Each of the Warburg Pincus Entities is a director-by-deputization solely for purposes of Section 16 of the Exchange Act.
- [F6]The Series A redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series A redeemable convertible preferred stock converted into approximately 0.0949 Shares. These shares had no expiration date.
- [F7]The Series B redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series B redeemable convertible preferred stock converted into approximately 0.1139 Shares. These shares had no expiration date.
- [F8]The Series C redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series C redeemable convertible preferred stock converted into approximately 0.1266 Shares. These shares had no expiration date.
- [F9]The Series D redeemable convertible preferred stock automatically converted into Common Stock upon the closing of the IPO. Each share of Series D redeemable convertible preferred stock converted into approximately 0.1671 Shares. These shares had no expiration date.